Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for degenerative disc disease.

S Sobajima1, J S Kim, L G Gilbertson

  • 1Ferguson Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Gene Therapy
|January 16, 2004
PubMed
Summary

Gene therapy offers a promising new approach to treat degenerative disc disease (DDD) by targeting the underlying cellular processes. Successful gene transfer in animal models paves the way for potential human clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro evaluation of translating and rotating plates using a robot testing system under follower load.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2015
Same author

Effects of secreted factors in culture medium of annulus fibrosus cells on microvascular endothelial cells: elucidating the possible pathomechanisms of matrix degradation and nerve in-growth in disc degeneration.

Osteoarthritis and cartilage·2013
Same author

Analysis of power law models for the creep of nucleus pulposus tissue.

Biorheology·2010
Same author

Application of a semiautomated contour segmentation tool to identify the intervertebral nucleus pulposus in MR images.

AJNR. American journal of neuroradiology·2010
Same author

p38 MAPK inhibition selectively mitigates inflammatory mediators and VEGF production in AF cells co-cultured with activated macrophage-like THP-1 cells.

Osteoarthritis and cartilage·2009
Same author

Biochemistry of intervertebral disc degeneration and the potential for gene therapy applications.

The spine journal : official journal of the North American Spine Society·2003

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Degenerative disc disease (DDD) leads to chronic pain and disability.
  • Current treatments for DDD are invasive and have limitations.
  • Aggrecan decline in the nucleus pulposus is a key feature of DDD.

Purpose of the Study:

  • To review the potential of gene therapy for treating DDD.
  • To explore methods for altering biological processes in degenerated intervertebral discs.
  • To outline future research needed for human clinical trials.

Main Methods:

  • Gene transfer to intervertebral disc cells in animal models.
  • Modulating extracellular matrix synthesis and catabolism.
  • Reviewing current advancements in gene therapy for DDD.

Related Experiment Videos

Main Results:

  • Successful in vivo gene transfer to intervertebral disc cells demonstrated.
  • Gene therapy shows potential to alter biological processes in degenerated discs.
  • Progress made towards developing gene therapy for DDD treatment.

Conclusions:

  • Gene therapy represents a novel, less invasive treatment strategy for DDD.
  • Further research is required to translate these findings into human clinical applications.
  • Targeting extracellular matrix components via gene therapy holds significant therapeutic promise.